Intralesional bleomycin for the treatment of periocular capillary hemangiomas

Simple item page
dc.contributor.authorSmit D.P.
dc.contributor.authorMeyer D.
dc.date.accessioned2012-08-17T12:41:20Z
dc.date.available2012-08-17T12:41:20Z
dc.date.issued2012
dc.descriptionArticle
dc.description.abstractPeriocular infantile capillary hemangiomas do not always respond well to conventional treatment modalities such as systemic or intralesional corticosteroids, radiotherapy or debulking surgery. The authors describe the use of intralesional bleomycin injections (IBIs) to treat potentially amblyogenic lesions in two cases where other modalities have failed. In both cases monthly IBIs successfully cleared the visual axis of the affected eye before the age of 1 year thus preventing permanent sensory deprivation amblyopia. A total of five and nine injections, respectively, were used and no significant side effects were noted. IBI appears to be a useful alternative in the treatment of periocular capillary hemangiomas refractory to more conventional modalities.
dc.identifier.citationIndian Journal of Ophthalmology
dc.identifier.citation60
dc.identifier.citation4
dc.identifier.citation326
dc.identifier.citation328
dc.identifier.issn3014738
dc.identifier.other10.4103/0301-4738.98722
dc.identifier.urihttp://hdl.handle.net/10019.1/49292
dc.subjectBleomycin
dc.subjectperiocular hemangiomas
dc.subjecttreatment
dc.titleIntralesional bleomycin for the treatment of periocular capillary hemangiomas
Files
Collections
Stellenbosch University - Scopus Publications